The recognition of human tRNA Leu or tRNA Ser by cognate aminoacyl-tRNA synthetases has distinct requirements. Only one base change (A73→G) in tRNA Leu is required to generate an efficient serine acceptor in vitro, whereas several changes in three structural domains (the acceptor stem, DHU loop and long extra arm) of tRNA Ser are necessary in order to produce a leucine acceptor. Hence, the molecular basis for the discrimination between human tRNA Ser and tRNA Leu by the seryl-tRNA synthetase depends almost exclusively on a highly specific recognition of the discriminator base G73. In order to elucidate the specific role of the functional groups of this base in discrimination, tRNA Ser constructs were made which contain the artificial base analogues 2-aminopurine riboside or inosine at the discriminator position 73. Aminoacylation of these constructs by a HeLa S100 extract showed that molecules with 2-aminopurine riboside, but not with inosine, in position 73 could be serylated at low efficiency. However, the 2-aminopurine riboside and the inosine derivatives of tRNA Ser were equally efficient competitive inhibitors of serylation, whereas tRNAs Ser with any other natural base at position 73 did not competitively inhibit serylation of tRNA Ser . This was in contrast to leucylation of tRNA Leu , where tRNA Leu transcripts with any other nucleotide in the discriminator position acted as strong competitive inhibitors. These results suggest that the discriminator bases in human tRNA Ser and tRNA Leu play completely different roles in recognition of the tRNAs by their cognate aminoacyl-tRNA synthetases.
INTRODUCTION
All tRNAs in any family and most tRNAs which accept chemically similar amino acids have the same residue at position 73, the discriminator base (1) . It is the only variable unpaired nucleotide near the site of aminoacylation except for tRNA His in archaebacteria, eubacteria or yeast mitochondria (2) and it has been shown that this nucleotide contributes to the identity of most tRNAs (3) (4) (5) (6) . Furthermore, the discriminator base plays a central and important role in the recognition of all human tRNAs with a long extra arm (class II tRNAs) by their cognate aminoacyl-tRNA synthetases because: (i) replacement of the leucine-specific discriminator base in human tRNA Leu by serine-specific G73 alone is sufficient for an identity switch to serine acceptance and for the complete loss of leucine identity (7); (ii) the reverse identity switch also requires the discriminator base and, in addition, several changes in three structural domains of tRNA Ser to generate an efficient leucine acceptor (8) ; (iii) the long extra arm and the discriminator base G73 are the major identity elements for the serylation of human tRNA Ser (9) and tRNA Sec (10) .
There are only a few reports that altered tRNA aminoacylation can be caused by single changes of amino, keto, hydroxyl or other chemical groups. They refer mainly to Escherichia coli tRNA Gln (11) and E.coli tRNA Ala (12, 13) . The 2-amino group of guanosines in positions 2, 3 and 10 of tRNA Gln is important for specific recognition by glutaminyl-tRNA synthetase (GlnRS) (11) . Substitution of guanosine residues with inosine allowed the identification of an unpaired 2-amino group of G3 essential for recognition by alanyl-tRNA synthetase (AlaRS) in the minor groove of the RNA (12) . Individual substitutions by 2′-deoxy or by 2′-O-methyl nucleotides have pinpointed three particular 2′-hydroxyl groups (C69, C71 and C72) in the RNA minor groove which may contact AlaRS (13) . In another case Pütz et al. (14) have shown that a single methyl group in m 1 G37 in tRNA Asp of yeast contributes to tRNA identity by preventing mischarging of tRNA Asp by yeast arginyl-tRNA synthetase.
An approach to understanding the function of the discriminator base and to characterizing essential functional elements within the discriminator base is to exchange the base or to introduce modifications of individual functional groups. Here we have studied the role of G73 in the interaction of serine-specific tRNAs with its cognate aminoacyl-tRNA synthetase (SerRS) by deletion of single functional groups in this base. Therefore, the discriminator base in human tRNA Ser was changed from G to 2-aminopurine riboside (2-AP) or to inosine (I). These altered tRNAs were used to study their roles as substrates for aminoacylation with regard to both catalytic and binding activity. Furthermore, tRNAs Ser with A, C or U and tRNAs Leu with C or G in position 73, which (Table 1) . Boxed RNA 3′-sequences were chemically synthesized. The 5′-moieties were prepared by T7 RNA polymerase transcription. Arrowheads identify the site of covalent joining of the two halves with T4 RNA ligase. Sequences characterized by bold lines correspond to the base pairing region of the complementary oligodeoxynucleotides added to the ligation assay. (A) tRNA Ser with a UGA anticodon (18) . Discriminator base substitutions are A73, C73, U73, 2-AP73 and I73 (2-AP = 2-aminopurine riboside; I = inosine). (B) tRNA Leu with a CAA anticodon (19) . The discriminator base A73 is replaced by G, C and U respectively. (C) Structures of 2-aminopurine riboside (2-AP), guanosine (G) and inosine (I).
do not serve as substrates for aminoacylation (7, 8) , were tested as potential competitive inhibitors for serylation and leucylation respectively.
MATERIALS AND METHODS

Enzymes and reagents
T7 RNA polymerase was prepared as described by Zawadzki and Gross (15) from an overproducing strain of E.coli kindly provided by Dr W. Studier. HeLa cytoplasmic S100 extract was prepared and dialysed as described by Dignam et al. (16) . Preincubation studies with this extract did not reveal any measurable degradation even of low amounts of tRNAs within 20 min. All other enzymes were obtained from commercial suppliers. [3-3 H]Serine (1.07 TBq/ mmol) and [4, H]leucine (1.9 TBq/mmol) were purchased from Amersham-Buchler (Braunschweig, Germany) and DuPont de Nemours (Bad Homburg, Germany) respectively. [α-32 P]dATP and [γ-32 P]ATP were obtained from Hartmann (Braunschweig, Germany). Tetrabutylammonium fluoride (1.1 M) in tetrahydrofuran was obtained from Aldrich (Steinheim, Germany). Oligoribonucleotides were prepared on an Applied Biosystems 380B DNA synthesizer by Drs T. Tuschl and F. Eckstein (Göttingen). They were base-deprotected and purified as described by Tuschl et al. (17) .
Bacterial strains and plasmids
Escherichia coli JM109 was used as host for propagation of plasmid pUC19 and its derivatives.
Construction of tDNA clones
The templates coding for tRNA Ser with a UGA anticodon (18) and tRNA Leu with a CAA anticodon (19) , including the T7 promoter and the BstNI recognition site, were assembled from synthetic oligodeoxynucleotides and cloned into pUC19. All subclones derived from these genes were constructed using appropriate synthetic oligodeoxynucleotides as polymerase chain reaction primers and were cloned into pUC19. The sequences of all constructs were confirmed by dideoxy sequencing (20) .
Preparation of tDNA transcripts
Transcription of BstBI-and BstNI-linearized tDNA templates and tRNA 5′-fragments (sequence from position 1 to 57, Fig. 1A and B) with T7 RNA polymerase yielded unmodified tRNAs, which were used for aminoacylation studies, and fragments for ligation reactions, respectively (Fig. 1) . The conditions for transcription with T7 RNA polymerase were as described by Achsel and Gross (9) .
The nucleoside at the 3′-end of tRNA fragments transcribed with T7 RNA polymerase was determined by 3′-end-labelling the tRNA fragment with 1.85 MBq [5′-32 P]pCp and T4 RNA ligase. The radioactive fragments were purified by 15% polyacrylamide (8 M urea) gel electrophoresis and ∼168 Bq of labelled tRNA fragment was then digested to completion with 0.05 U RNase T2 in 20 µl 5 mM NH 4 OAc, pH 4.6, at 37_C for at least 5 h. Nucleoside 3′-monophosphates were identified by thin layer chromatography according to Nishimura (21) .
Ligation of inosine-and 2-aminopurine ribosidecontaining oligoribonucleotides with T4 RNA ligase
Synthetic inosine (I73)-, 2-aminopurine riboside (2-AP73)-and G73-containing 19mer ribonucleotides spanning the sequence from position 58 to 76 of tRNA Ser (Fig. 1A ) and a tRNA Leu -specific oligoribonucleotide of the same length ( Fig. 1B) with the discriminator base A73 were chemically synthesized (17) . These chemically synthesized donor oligoribonucleotides (identified by boxed sequences in Fig. 1A and B) were phosphorylated at their 5′-ends with T4 polynucleotide kinase according to the supplier's instructions. For the ligation reaction the 5′-phosphorylated donor oligoribonucleotide (17.5 µM, 3-fold molar excess), the 3′-OH acceptor tRNA fragment (5.8 µM), the ligation buffer (10×, 10 µl) and 100 U T4 RNA ligase (Boehringer) were combined in a final volume of 100 µl and incubated at 37_C for 2 h. For efficient ligation of the serine-specific tRNA fragments an oligodeoxynucleotide (29 µM, 5-fold molar excess) pairing to the DHU loop and stem domain of the tRNA 5′-fragment was added (Fig. 1A) . The reaction was then carried out as mentioned above. Product and substrate were separated by electrophoresis in a denaturing 8 M urea gel of 10% polyacrylamide for preparative separations or 20% gels for analytical purposes.
In vitro aminoacylation
All tRNAs were heated for 4 min at 68_C in 5 mM MgCl 2 and allowed to cool slowly to room temperature. Leucine-specific aminoacylation was at 37_C in 36 µl containing 20 mM imidazole-HCl, pH 7.5, 75 mM KCl, 6 mM MgCl 2 , 5 mM ATP, 0.5 mM CTP, 0.5 mM DTT, 3.3% (v/v) dialysed HeLa cytoplasmic S100 extract (16) (8.1 mg protein/ml) and 5 µM leucine, which included 0.38 µM [4,5-3 H]leucine (1.9 TBq/ mmol). tRNA concentrations ranged from 1.0 to 10 µM. Serine-specific aminoacylation was also performed at 37_C in 36 µl of a reaction mixture containing 20 mM imidazole-HCl, pH 7.5, 150 mM KCl, 10 mM MgCl 2 , 5 mM ATP, 0.5 mM CTP, 0.5 mM DTT, 3.3% (v/v) HeLa cytoplasmic S100 extract (8.1 mg protein/ml) and 5 µM serine, which included 0.7 µM [3-3 H]serine (1.07 TBq/mmol). tRNA concentrations ranged from 0.4 to 4 µM. Samples (6 µl) of the reaction mixture were transferred onto pieces of Whatman 3MM paper which were washed with 10% trichloroacetic acid, twice in 5% trichloroacetic acid and twice in ethanol to remove free [ 3 H]amino acids. Radiolabelled aminoacyltRNA was then measured by liquid scintillation counting.
Competitive inhibition of aminoacylation
Aminoacylations were carried out as mentioned above. tRNA transcripts serving as potential inhibitors were added to reaction mixtures in 10-fold molar excess (4 and 10 µM respectively) with regard to tRNA Ser or tRNA Leu . An increase in the concentrations of tRNA Ser or tRNA Leu without changing the concentration of the inhibitors leads to abolition of the inhibition, indicating a competitive interaction at the active centre of the aminoacyl-tRNA synthetase.
RESULTS
Design of tRNA Ser molecules with modified nucleosides at the discriminator position 73
T4 RNA ligase was used to connect specific tRNA fragments to construct a mature tRNA with modified nucleosides at the Figure 2 . Separation of substrates and ligation products of tRNA Ser and tRNA Leu on a 20% denaturing polyacrylamide (8 M urea) gel stained with toluidine blue. Lane 1, human tRNA Ser transcribed with T7 RNA polymerase; lane 2, tRNA Ser 5′-fragment transcribed with T7 RNA polymerase as used for the ligation reaction; lanes 3 and 5, ligation assay of serine-specific tRNA 5′-and 3′-fragments in the presence of the additional hybridizing oligodeoxynucleotide (Fig. 1A) ; lane 4, the same reaction as in lanes 3 and 5 but without addition of the oligodeoxynucleotide; lane 6, ligation assay of leucine-specific tRNA 5′-and 3′-fragments in the presence of the additional hybridizing oligodeoxynucleotide (Fig. 1B) ; lane 7, ligation of leucine-specific tRNA fragments without addition of the oligodeoxynucleotide. (a) mature tRNA; (b) tRNA 5′-fragment generated by T7 RNA polymerase transcription. discriminator position 73. One tRNA fragment was based on either tRNA Ser -or tRNA Leu -specific sequence from position 1 of the 5′-site of the acceptor stem and ending at position 57 with the universal, highly conserved sequence 5′-UUCGOH-3′ (Fig. 1A and B). These fragments were transcribed by T7 RNA polymerase from corresponding DNA templates. Analysis of the last nucleoside at the 3′-site of these tRNA fragments showed that the 3′-ends were always correct, ending with residue G (not shown). The fragments from position 58 to the 3′-end were chemically synthesized oligoribonucleotides (19mers) containing residue G or the modified purines inosine or 2-aminopurine riboside at the discriminator position for construction of human tRNA Ser and its derivatives and adenosine for generation of tRNA Leu (Fig. 1) . The acceptor stem and TΨC stem domains of each fragment were annealed to each other (Fig. 1A and B) . Covalent joining of the two tRNA halves with T4 RNA ligase was facilitated and the generation of by-products was avoided because the two fragments were partially hydrogen bonded and the sites to be ligated were in proximal neighbourhood.
The use of an oligodeoxynucleotide hybridizing to the DHU domain can dramatically facilitate ligation in the TΨC loop Figure 2 shows ligation products and substrates of tRNA Ser and tRNA Leu separated in a 20% denaturing polyacrylamide (8 M urea) gel and stained with toluidine blue. Lanes 3-5 show the products of ligation reactions used for construction of human tRNA Ser . The reaction mixture shown in lanes 3 and 5 contained an additional oligodeoxynucleotide, pairing to the DHU stem and loop domain of the longer tRNA fragment that had been transcribed with T7 RNA polymerase (Fig. 1A) . These reactions yielded substantial amounts of the ligated product, which co-migrated with tRNA Ser (lane 1). When the reaction mixture did not contain the additional pairing oligodeoxynucleotide little or no ligation product was produced (lane 4). Therefore, for efficient ligation an oligodeoxynucleotide masking the complete DHU stem and loop domain of the tRNA Ser 5′-fragment must be added, possibly to prevent an unfavourable tertiary structure. In contrast, addition of a corresponding oligodeoxynucleotide to the ligation reaction mixture containing the two tRNA Leu halves inhibited ligation Figure 3 . Kinetics of serylation of human tRNA Ser in HeLa cytoplasmic S100 extract. tRNA Ser (Y) was generated by complete transcription with T7 RNA polymerase; tRNA Ser (∆), tRNA Ser 2-AP73 (j) and tRNA Ser I73 (×) were generated by covalent joining of two tRNA fragments (Fig. 1A) with T4 RNA ligase. tRNA concentrations of 1.0 µM were used. The coupling yields of inosine and 2-aminopurine riboside phosphoramidites monitored by trityl group release were measured to be >99% (17) . It is unknown whether the low rate of tRNA Ser 2-AP73 serylation is caused by slow aminoacylation or by competition between aminoacylation and rapid hydrolysis of the ester bond. (Fig. 2, lane 6) , whereas the reaction mixture without the oligodeoxynucleotide yielded complete tRNA Leu (Fig. 2, lane 7) . The sequences of leucine-and serine-specific tRNA fragments at the site of covalent joining are identical (Fig. 1A and B) . In all reactions formation of other than the major product was rare. When the tRNA Leu halves were annealed by hydrogen bonding the structure formed could be leucylated, although only to a small extent (not shown), which suggests that a correct tRNA Leu -like tertiary structure had formed. In contrast, the product of annealing the halves of tRNA Ser could not be serylated. This suggests that intramolecular tertiary interactions in tRNA Leu and tRNA Ser , such as those between DHU and TΨC loop nucleotides, are different in both tRNAs.
2-Aminopurine riboside but not inosine in the discriminator position 73 allows serylation with low efficiency
The serine-specific discriminator base G (Fig. 1C) contains two exocyclic functional groups which can potentially form hydrogen bonds with SerRS: (i) the NH 2 group at position two of the purine ring; (ii) the O 6 -keto group. To study the functions and roles of these chemical groups either the amino or the keto group was deleted. Analogues of guanosine such as inosine and 2-aminopurine riboside were incorporated (Fig. 1C) . The guanosine analogue inosine lacks the exocyclic 2-amino group, whereas in 2-aminopurine riboside the O 6 -keto function was deleted. Four different kind of tRNA species were constructed by ligation with T4 RNA ligase: tRNA Leu , tRNA Ser , tRNA Ser with the modified nucleoside (Fig. 3) . Corresponding results were obtained for the tRNA Leu transcript and for ligated tRNA Leu (not shown). tRNA Ser I73 cannot be charged with serine, whereas tRNA Ser 2-AP73 can be serylated, albeit weakly (Fig. 3) . tRNA Ser with any other natural base at position 73 cannot be aminoacylated by SerRS (Table 1; ref. 7) . Thus the exocyclic 2-amino group of G73 is absolutely required for serylation.
Both tRNA Ser 2-AP73 and tRNA Ser I73 competitively inhibit aminoacylation of human tRNA Ser
The fact that tRNA Ser 2-AP73 is weakly serylated and tRNA Ser I73 is not raised the question whether the latter nevertheless interacts with SerRS. For this purpose human tRNA Ser was aminoacylated in the presence of tRNA Ser I73, tRNA Ser 2-AP73 or tRNA Ser transcripts which contained the discriminator base A, C or U (tRNA Ser A73, tRNA Ser C73 or tRNA Ser U73) or tRNA Leu as potential inhibitors. These tRNAs were added in 10-fold molar excess with regard to the tRNA Ser transcript (Fig. 4) . Similar competitive inhibition by tRNA Ser 2-AP73 and tRNA Ser I73 was determined, however, no inhibition of serylation could be observed in the presence of tRNA Ser A73, tRNA Ser C73, tRNA Ser U73 or tRNA Leu (Table 1 and Fig. 4) . These results show that at least one guanine-specific group (O 6 or NH 2 2 ) is needed in the purine ring for interaction with SerRS. 
The discriminator base A73 does not play a dominant role in interaction with leucyl-tRNA synthetase
Modified tRNA Leu transcripts were added to the standard aminoacylation assay in up to 10-fold molar excess with regard to tRNA Leu . tRNA Leu transcripts containing residues C and G at position 73 (tRNA Leu C73 and tRNA Leu G73), human tRNA Ser , tRNA Ser A73 or a pre-tRNA Tyr from Arabidopsis thaliana with an intron were used as potential inhibitors. Addition of pre-tRNA Tyr had no effect on leucylation efficiency and of tRNA Ser and tRNA Ser A73 had little effect (Table 1 and Fig. 5 ). However, addition of either tRNA Leu G73 or tRNA Leu C73 strongly decreased leucylation of tRNA Leu (Table 1 and Fig. 5 ), tRNA Leu C73 having a greater effect than tRNA Leu G73 (Fig. 5 ). These results demonstrate that the discriminator base of human tRNA Leu does not play a significant role in interaction with leucyl-tRNA synthetase (LeuRS) and suggest that a correct tRNA Leu -specific tertiary structure is much more important.
DISCUSSION
We have achieved a remarkable advance in knowledge about the different modes of interaction of tRNA Ser and tRNA Leu with their cognate synthetases by the incorporation of different base analogues into the discriminator position 73 of these tRNAs. Both functional groups, NH 2 2 and O 6 , of the human tRNA Ser discriminator base G73 are essential for binding to SerRS. However, 2-aminopurine riboside, but not inosine, in the discriminator position 73 allowed serylation, which indicates the importance of the exocyclic 2-amino group of G73 in the catalytic step, possibly for a correct positioning of the CCA 3′-end at the catalytic site of SerRS. tRNAs Ser with any other natural base in position 73 did not act as competitive inhibitors and hence do not interact with SerRS. X-ray analyses of the crystallographic structures of SerRS-tRNA Ser complexes of Thermus thermophilus and E.coli unfortunately do not reveal any detailed data about the four single-stranded nucleotides at the 3′-end of these tRNAs (22, 23) .
The roles of the discriminator bases in human tRNA Leu and tRNA Ser are clearly different. Not only is tRNA Leu with U73 leucylated with low efficiency (8, 9) , in contrast to similarly modified tRNA Ser , but tRNA Leu molecules with C73 or G73 strongly inhibit leucylation of human tRNA Leu , whereas tRNA Ser and tRNA Ser A73 are only weak inhibitors. This indicates the necessity of a tRNA Leu -like tertiary structure, which seems to be more important than the correct discriminator base for binding to LeuRS. The absence of any effect of pre-tRNA Tyr on LeuRS (Fig. 5) indicates that non-specific inhibition did not occur under our conditions. It should be noted that all data were obtained with impure enzyme fractions (HeLa cytoplasmic S100 extract), as is usual for many studies with human enzymes, with the advantage of a general in vivo-like competition between all aminoacyltRNA synthetases.
There is no evidence to indicate whether the functional groups of the serine-specific discriminator base G interact directly with SerRS or whether they cause a structural change in the first base pair of the acceptor stem to achieve an efficient interaction with the cognate synthetase. It has been demonstrated recently that the discriminator base plays a crucial role in influencing tRNA structure. Lee et al. (24) have shown that exchange of the discriminator base from A73 to either C73 or U73 makes the C in the C1:G72 base pair of mutant E.coli initiator tRNAs more reactive toward the single-strand-specific reagent sodium bisulfite. The activity of the enzyme Met-tRNA transformylase toward these tRNAs is also consistent with destabilization of the C1:G72 base pair. A more detailed picture is given by NMR studies of variant acceptor stem hairpins of initiator tRNA fMet , which clearly demonstrated that a discriminator base change (A73→U) affected the conformation at the 3′-CCA end (25) . However, it is not known if these influences of the discriminator bases A or U are only specific for tRNA fMet , which has an unpaired terminal base pair C1:A72 in the wild-type form.
The discriminator base G73 has been proposed to act as a determinant of tRNA Gln identity (26) (27) (28) (29) (30) . Base substitutions with pyrimidines at this position were harmful to recognition of the cognate enzyme, whereas substitution with A73 had little effect on aminoacylation. Rould et al. (26) have shown that in the GlnRS-tRNA Gln complex the exocyclic 2-amino group of G73 forms a hydrogen bond with the phosphate oxygen of the adjacent nucleotide at position 72. This interaction stabilizes a hairpin turn at the 3′-end, which positions the acceptor stem for aminoacylation. In this context it is noteworthy that both an acceptor stem microhelix Gln , which is aminoacylated by GlnRS, and its variant with C73 as discriminator base, which is not aminoacylated by GlnRS, can act as competitive inhibitors of tRNA Gln aminoacylation (31) . However, the role of the discriminator base in the yeast AspRS-tRNA Asp interaction differs in that the enzyme contacts the discriminator base directly (32, 33) . In contrast to GlnRS, AspRS approaches the tRNA from the major groove side of the helical amino acid acceptor stem and an undistorted helical conformation of the acceptor stem is maintained up to C74. In the case of an alanine minihelix the nature of the discriminator base appears to be a critical determinant of the transition state for the reaction of bound alanyl adenylate with RNA (34).
It is not known in which, or if in either, of these ways human SerRS interacts with tRNA Ser . SerRS differs from all other aminoacyl-tRNA synthetases in an exceptional flexibility in tRNA substrate recognition and interaction, as for example in the efficient serylation of the three very different substrates tRNA Sec , tRNA Ser and tRNA Leu G73 (7) . Discrimination between both tRNA Sec and tRNA Ser and the only other structurally similar tRNA, tRNA Leu , with a long extra arm, is therefore predominantly enforced by the discriminator base.
